Clinical Trials Logo

Generalized Anxiety Disorder clinical trials

View clinical trials related to Generalized Anxiety Disorder.

Filter by:

NCT ID: NCT01033851 Completed - Clinical trials for Generalized Anxiety Disorder

Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects

Start date: March 2008
Phase: Phase 4
Study type: Interventional

Current therapies for Generalized Anxiety Disorder (GAD) have limited effectiveness. This study measures the efficacy of two different approaches to reducing anxiety and stress. One approach uses education, nutrition, exercise, and time management training, and another uses mindfulness meditation and yoga, which is taught as part of the Mindfulness-based stress reduction (MBSR) course, an 8-week manualized mindfulness intervention. We hypothesize that the two approaches will reduce anxiety in individuals with GAD in different ways. We will measure changes in stress hormones associated with these changes.

NCT ID: NCT01032473 Recruiting - Clinical trials for Generalized Anxiety Disorder

Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD)

Start date: August 2009
Phase: N/A
Study type: Observational

Anxiety disorders are among the most common mental disorders in children, affecting approximately 1 out of every 10 children and adolescents. Symptoms of anxiety disorders may include excessive fear/anxiety/worry, somatic complaints such as headaches and muscle aches, and impaired social and family relationships. Some children with anxiety also experience sleep problems, however, little is known about the sleep patterns of anxious children. The purpose of the study, conducted at Children's National Medical Center, is to examine the sleep characteristics of children with Generalized Anxiety Disorder (GAD) compared to a control group of children without GAD to see how sleep behaviors and daytime behaviors are related.

NCT ID: NCT00961493 Completed - Clinical trials for Generalized Anxiety Disorder

RCT of an Acceptance-based Behavior Therapy for GAD

Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether acceptance-based behavior therapy for GAD results in greater symptom reduction and increased quality of life than applied relaxation.

NCT ID: NCT00961298 Completed - Clinical trials for Irritable Bowel Syndrome

An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder

Start date: September 2009
Phase: Phase 4
Study type: Interventional

The investigators propose to evaluate the effectiveness of duloxetine in treating subjects with both Irritable Bowel Syndrome (IBS) and Generalized Anxiety Disorder (GAD). The investigators hypothesize that duloxetine as a single therapeutic agent will effectively target pain and other core symptoms of IBS as well as GAD in this patient population with both conditions.

NCT ID: NCT00953654 Completed - Clinical trials for Generalized Anxiety Disorder

Exercise Training for the Treatment of Generalized Anxiety Disorder

Start date: August 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of 6 weeks of endurance or strength training and a wait list comparison condition on symptoms of Generalized Anxiety Disorder (GAD).

NCT ID: NCT00951652 Completed - Clinical trials for Generalized Anxiety Disorder

Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder

Start date: July 1998
Phase: N/A
Study type: Interventional

This study will test a version of cognitive behavioral therapy for generalized anxiety disorders that incorporates interpersonal and emotional processing techniques.

NCT ID: NCT00951340 Completed - Clinical trials for Generalized Anxiety Disorder

Desensitization and Cognitive Therapy in General Anxiety.

Start date: July 1996
Phase: Phase 1
Study type: Interventional

This study will test the feasibility and safety of adding interpersonal and emotional processing techniques to standard cognitive behavioral therapy for generalized anxiety disorder.

NCT ID: NCT00947570 Completed - Anxiety Disorders Clinical Trials

Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study)

Start date: October 2007
Phase: N/A
Study type: Interventional

This study will examine the effects of cognitive behavioral therapy on brain function in people with anxiety disorders.

NCT ID: NCT00938093 Completed - Clinical trials for Generalized Anxiety Disorder

Treatment of Late-life Anxiety in Primary Care Settings

Start date: March 2006
Phase: N/A
Study type: Interventional

The research study proposed is designed to examine the outcomes of a cognitive behavioral guided self-care intervention with older adults diagnosed with generalized anxiety disorder and recruited from a primary care setting. It is hypothesized that the cognitive behavioral guided self-care intervention will produce greater declines in worry and anxiety than enhanced usual care.

NCT ID: NCT00921063 Completed - Clinical trials for Generalized Anxiety Disorder

A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

Start date: November 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of PD 0332334 compared to placebo in the treatment of Generalized Anxiety Disorder in an adult population